ES2010786A6 - Metodo para preparar nuecleosidos y nucleotidos mejoradores del sistema antiviral, antitumoral, antimetastatico e inmune. - Google Patents

Metodo para preparar nuecleosidos y nucleotidos mejoradores del sistema antiviral, antitumoral, antimetastatico e inmune.

Info

Publication number
ES2010786A6
ES2010786A6 ES8802722A ES8802722A ES2010786A6 ES 2010786 A6 ES2010786 A6 ES 2010786A6 ES 8802722 A ES8802722 A ES 8802722A ES 8802722 A ES8802722 A ES 8802722A ES 2010786 A6 ES2010786 A6 ES 2010786A6
Authority
ES
Spain
Prior art keywords
antimetastatic
nucleotides
immune system
system enhancing
enhancing nucleosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802722A
Other languages
English (en)
Inventor
Roland Kenith Robins
Howard Brinker Cottam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/136,020 external-priority patent/US4880784A/en
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of ES2010786A6 publication Critical patent/ES2010786A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

METODO PARA PREPARAR NUCLEOSIDOS Y NUCLEOTIDOS MEJORADORES DEL SISTEMA ANTIVIRAL, ANTITUMORAL, ANTIMETASTASICO E INMUNE QUE RESPONDEN A LA ESTRUCTURA: DONDE R4-R7 SON H, OH U O-ACILO C1-C18, R3 ES H, ACILO, C1-C18 U OP(OH2)2-, O R5 Y R7 SON H U OH, R6 ES H Y R3 Y R4 JUNTOS SON OPO(OH)-, X ES =O O =S, Y ES -OH, -SH, -NH2 O HALOGENO, Y Z ES H, -NH2, -OH O HALOGENO, SIENDO EL HALOGENO CL O BR. CONSISTE EN FORMAR UN DERIVADO SILILO DE UNA TIAZOLO[4,5-D]PIRIMIDINA 2,5,7-SUSTITUIDA, HACER REACCIONAR DICHO DERIVADO SILILO CON 1-SUSTITUIDO-BLOQUEADO-D-PENTOFURANOSA, EN PRESENCIA DE UN CATALIZADOR, FORMANDO UN NUCLEOSIDO BLOQUEADO, Y DESBLOQUEAR DICHO NUCLEOSIDO. LOS PRODUCTOS OBTENIDOS SON UTILES PARA TRATAR ENFERMEDADES VIRALES Y TUMORES EN MAMIFEROS.
ES8802722A 1987-12-21 1988-09-03 Metodo para preparar nuecleosidos y nucleotidos mejoradores del sistema antiviral, antitumoral, antimetastatico e inmune. Expired ES2010786A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/136,020 US4880784A (en) 1987-12-21 1987-12-21 Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US07/236,366 US5041426A (en) 1987-12-21 1988-08-25 Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides

Publications (1)

Publication Number Publication Date
ES2010786A6 true ES2010786A6 (es) 1989-12-01

Family

ID=26833912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802722A Expired ES2010786A6 (es) 1987-12-21 1988-09-03 Metodo para preparar nuecleosidos y nucleotidos mejoradores del sistema antiviral, antitumoral, antimetastatico e inmune.

Country Status (11)

Country Link
US (1) US5041426A (es)
EP (2) EP0348446B1 (es)
JP (1) JP2590248B2 (es)
KR (1) KR970002611B1 (es)
AR (1) AR246104A1 (es)
AT (2) ATE173929T1 (es)
CA (1) CA1319931C (es)
DE (2) DE3856279T2 (es)
DK (1) DK406389A (es)
ES (1) ES2010786A6 (es)
WO (1) WO1989005649A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
AU3760489A (en) * 1988-05-23 1989-12-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Derivatives of cyclic amp as treatment for cancer
ATE271063T1 (de) * 1996-10-16 2004-07-15 Icn Pharmaceuticals Purin-l-nukleoside, deren analoga und verwendungen
US6509320B1 (en) * 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
EP1103559A1 (en) * 1997-01-17 2001-05-30 ICN Pharmaceuticals, Inc. Autoimmune nucleosides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US6645990B2 (en) * 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
GEP20074099B (en) * 2001-11-27 2007-05-10 Anadys Pharmaceuticals Inc 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
KR20060096415A (ko) * 2003-09-05 2006-09-11 애나디스 파마슈티칼스, 인코포레이티드 Ｃ형 간염 바이러스에 의한 감염증을 치료하기 위해투여하는 ｔｌｒ７ 리간드 및 이의 전구약물
CN1845745B (zh) * 2003-09-05 2011-11-02 安那迪斯药品股份有限公司 Tlr7配体及其前药在制备用于治疗丙型肝炎病毒感染的药物中的用途
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
JP4856638B2 (ja) * 2004-06-07 2012-01-18 アナディス・ファーマシューティカルズ・インコーポレイテッド ３−β−Ｄ−リボフラノシルチアゾロ［４，５−ｄ］ピリミジンヌクレオシドおよびその使用
CN101212968B (zh) * 2004-12-17 2011-11-16 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
MY176938A (en) * 2004-12-17 2020-08-27 Anadys Pharmaceuticals Inc 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof
JP5117391B2 (ja) * 2005-11-21 2013-01-16 アナディス ファーマシューティカルズ インク ５−アミノ−３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オンを調製するための新規な方法
ES2543840T3 (es) 2006-04-11 2015-08-24 Novartis Ag Inhibidores espirocíclicos del VHC/VIH y sus usos
CN101516192B (zh) * 2006-06-22 2012-09-19 安那迪斯药品股份有限公司 5-氨基-3-(3'-脱氧-β-D-呋喃核糖基)-噻唑并[4,5-d]嘧啶-2,7-二酮的前药
WO2008011406A2 (en) 2006-07-18 2008-01-24 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
KR100880298B1 (ko) 2006-12-06 2009-01-28 애나디스 파마슈티칼스, 인코포레이티드 ３-β-Ｄ-리보푸라노실티아졸로[４,５-ｄ]피리미딘뉴클레오시드 및 이의 용도
PE20120106A1 (es) 2008-12-09 2012-02-20 Gilead Sciences Inc Moduladores de receptores tipo toll
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
PT2752422T (pt) 2010-03-31 2017-11-07 Gilead Pharmasset Llc Síntese estereosseletiva de princípios ativos contendo fósforo
AU2011311880B2 (en) 2010-10-08 2014-07-24 Novartis Ag Vitamin E formulations of sulfamide NS3 inhibitors
WO2012102366A1 (ja) * 2011-01-28 2012-08-02 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
JP6522732B2 (ja) 2014-07-11 2019-05-29 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖを治療するためのトール様受容体の調節因子
CA2960436C (en) 2014-09-16 2021-01-05 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator
ES2864223T3 (es) 2014-12-08 2021-10-13 Hoffmann La Roche Compuestos de 5-amino-6H-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituida para el tratamiento y profilaxis de infección vírica
PE20171648A1 (es) 2015-03-16 2017-11-13 Hoffmann La Roche Tratamiento combinado con un agonista de tlr7 y un inhibidor del ensamblaje de la capsida del vhb
CN107743491B (zh) 2015-05-08 2020-08-21 豪夫迈·罗氏有限公司 用于治疗和预防病毒感染的新的氧硫杂环戊烷甲酸及其衍生物
EP4001283A1 (en) 2015-05-12 2022-05-25 F. Hoffmann-La Roche AG Substituted aminothiazolopyrimidinedione derivatives for the treatment and prophylaxis of virus infection
EP3317289B1 (en) 2015-06-30 2021-10-27 F. Hoffmann-La Roche AG Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
BR112019013884A2 (pt) 2017-01-06 2020-03-03 F. Hoffmann-La Roche Ag Processo para a preparação de compostos de 5 -amino -6h´ -tiazolo [4,5 -d] pirimidina -2,7 -diona 3 -substituídos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals

Also Published As

Publication number Publication date
CA1319931C (en) 1993-07-06
DK406389A (da) 1989-10-04
AR246104A1 (es) 1994-03-30
DE3856279D1 (de) 1999-01-14
EP0348446A4 (en) 1991-09-25
JPH03504122A (ja) 1991-09-12
JP2590248B2 (ja) 1997-03-12
DE3856279T2 (de) 1999-05-20
EP0348446B1 (en) 1995-08-09
EP0636372A1 (en) 1995-02-01
US5041426A (en) 1991-08-20
ATE173929T1 (de) 1998-12-15
ATE126060T1 (de) 1995-08-15
DK406389D0 (da) 1989-08-18
DE3854297T2 (de) 1996-03-28
DE3854297D1 (de) 1995-09-14
KR970002611B1 (en) 1997-03-06
KR900700106A (ko) 1990-08-11
EP0636372B1 (en) 1998-12-02
WO1989005649A1 (en) 1989-06-29
EP0348446A1 (en) 1990-01-03

Similar Documents

Publication Publication Date Title
ES2010786A6 (es) Metodo para preparar nuecleosidos y nucleotidos mejoradores del sistema antiviral, antitumoral, antimetastatico e inmune.
DK0666749T3 (da) Enantiomert rene beta-D-dioxalannukleosider med selektiv antihepatitis B virus aktivitet
MY104575A (en) Therapeutic nucleosides.
UA29382C2 (uk) Карбоциклічні нуклеозиди 6-заміщеного пурину
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
MY102693A (en) Antiviral nucleosides
MY130035A (en) Antiviral compounds
EP0625991A4 (en) IMPROVED ALPHA INTERFERON COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF FROM LEUKOCYTES OF THE HUMAN PERIPHERAL BLOOD.
DE3370587D1 (en) Compositions comprising interferon and their therapeutic use
ZA939677B (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
ZA931647B (en) Therapeutic nucleosides
PT1119370E (pt) Inversao do estado de choque sistemico e de dificuldade respiratoria originado por inducao viral por meio do bloqueio da via da linfotoxina beta
ES2120962T3 (es) Composicion antivirica.
GB8726136D0 (en) Therapeutic nucleosides
MY105855A (en) Therapeutic nucleotides.
EP0272579A3 (en) Refractory shields for curved and straight superheater tubes
ES2103811T3 (es) Terapia antiviral.
EP0459176A3 (en) Oligophosphates with antiviral activity
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
HK1012234A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
ZA916542B (en) New phospholipid derivatives of nucleosides,processes for their preparation and antiviral use
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
CY2338B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections.
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
IE880770L (en) Treatment of viral infections

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-09-03

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20080904